Alpha-2 macroglobulin - Revision history

WikiSysop at 10:25, 10 March 2015

2015-03-10T10:25:16Z

WikiSysop at 07:06, 18 September 2007

2007-09-18T07:06:39Z

Berci Meskó: Undo revision 991 by Special:Contributions/Berci Meskó (User talk:Berci Meskó)

2007-08-27T06:49:34Z

Undo revision 991 by Special:Contributions/Berci Meskó (User talk:Berci Meskó)

Berci Meskó: first try

2007-08-27T06:49:05Z

first try

WikiSysop: Alpha-2 macroglobulin (FXIIIa) moved to Alpha-2 macroglobulin

2007-07-25T04:49:45Z

Alpha-2 macroglobulin (FXIIIa) moved to Alpha-2 macroglobulin

WikiSysop: Alpha-2 macroglobulin moved to Alpha-2 macroglobulin (FXIIIa)

2007-07-25T04:47:34Z

Alpha-2 macroglobulin moved to Alpha-2 macroglobulin (FXIIIa)

WikiSysop at 07:05, 24 July 2007

2007-07-24T07:05:49Z

WikiSysop: New page: {{Subst:infobox13}}

2007-07-24T07:04:11Z

New page: {{Subst:infobox13}}

New page

{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''
|-
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
|-
| Substrate peptide name
| {{PAGENAME}}
|-
| Synonyms
| -
|-
| Determination type
| In situ
|-
| Source
| Homo sapiens
|-
| Subcellular localization
| Cytoskeleton
|-
| Swissprot ID
| [http://au.expasy.org/uniprot/P08865 P08865]
|-
| Reactive glutamines
| [[Q41 (Actin)|Q41]]
|-
| Reactive lysines
| Not determined yet
|-
| Substrate sequence
| GRPRHQGVMVG
|-
| Structure
| [http://www.rcsb.org/pdb/explore/explore.do?structureId=2BTF 2BTF]
|-
| Surface accessibility
| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
|-
| Disorder prediction
| [http://iupred.enzim.hu/index.html IUPred]
|-
| Reference
| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=9252372&dopt=Abstract PMID:9252372]
|-
| Notes
|
|-
| {{infobox header}} |
|-
|}

[[Category:FXIIIa|*]]

← Older revision		Revision as of 06:49, 27 August 2007
Line 51:		Line 51:

	[[Category:FXIIIa\|*]]		[[Category:FXIIIa\|*]]
−
−	~~<googlevideo>7204448316935367667</googlevideo>~~

← Older revision		Revision as of 06:49, 27 August 2007
Line 51:		Line 51:

	[[Category:FXIIIa\|*]]		[[Category:FXIIIa\|*]]
		+
		+	<googlevideo>7204448316935367667</googlevideo>

@@ Line 1: / Line 1: @@
-{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
+{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" {infobox header}| '''{{PAGENAME}}'''
 |-
 | align="center" colspan="2" bgcolor="#ffffff" |
@@ Line 46: / Line 45: @@
+|
 |-
-| {{infobox header}} |
+| {infobox header} |
 |-
 |}
 [[Category:FXIIIa|*]]

@@ Line 2: / Line 2: @@
 ! {{infobox header}}| '''{{PAGENAME}}'''
 |-
-| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
+| align="center" colspan="2" bgcolor="#ffffff" |
 |-
 | Substrate peptide name

← Older revision	Revision as of 04:49, 25 July 2007
(No difference)

← Older revision	Revision as of 04:47, 25 July 2007
(No difference)

@@ Line 1: / Line 1: @@
 {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
 ! {{infobox header}}| '''{{PAGENAME}}'''
@@ Line 12: / Line 11: @@
 |-
 | Determination type
-| In situ
+| In vitro
 |-
 | Source
@@ Line 18: / Line 17: @@
 |-
 | Subcellular localization
-| Cytoskeleton
+| Extracellular; plasma
 |-
 | Swissprot ID
-| [http://au.expasy.org/uniprot/P08865 P08865]
+| [http://au.expasy.org/uniprot/P01023 P01023 ]
 |-
 | Reactive glutamines
-| [[Q41 (Actin)|Q41]]
+| Q670
 |-
 | Reactive lysines
-| Not determined yet
+| -
 |-
 | Substrate sequence
-| GRPRHQGVMVG
+| MCPQLQ''Q''YEMHG
 |-
 | Structure
-| [http://www.rcsb.org/pdb/explore/explore.do?structureId=2BTF 2BTF]
+| No available crystal structure
 |-
 | Surface accessibility
-| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
 |-
 | Disorder prediction
@@ Line 42: / Line 41: @@
 |-
 | Reference
-| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=9252372&dopt=Abstract PMID:9252372]
+| [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=6169549&dopt=Abstract PMID:6169549]
 |-
 | Notes